Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › CA › LAKE ISABELLA › KERN VALLEY HEALTHCARE DISTRICT

KERN VALLEY HEALTHCARE DISTRICT

NPI: 1427049964 · LAKE ISABELLA, CA 93240 · Skilled Nursing Facility · NPI assigned 11/03/2005

$13.18M
Total Medicaid Paid
298,227
Total Claims
252,887
Beneficiaries
174
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialOLSON, JEANNE (BUSINESS OFFICE MANAGER)
NPI Enumeration Date11/03/2005

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 44,423 $2.71M
2019 45,962 $2.61M
2020 39,176 $1.39M
2021 41,513 $1.57M
2022 43,433 $1.61M
2023 46,130 $1.87M
2024 37,590 $1.42M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99283 Emergency department visit for the evaluation and management, moderate severity 13,429 12,411 $2.57M
T1015 Clinic visit/encounter, all-inclusive 11,122 9,070 $2.53M
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 9,839 8,856 $2.25M
0450 Emergency room services 8,060 7,119 $862K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 25,809 22,146 $796K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 11,922 2,820 $609K
0270 5,201 4,480 $385K
99284 Emergency department visit for the evaluation and management, high severity 4,722 4,598 $373K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 9,046 8,073 $323K
Q3014 Telehealth originating site facility fee 8,286 6,643 $186K
99215 Prolong outpt/office vis 3,917 2,576 $163K
74177 Computed tomography, abdomen and pelvis; with contrast material 1,499 1,452 $146K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 5,847 5,427 $127K
70450 Computed tomography, head or brain; without contrast material 2,216 2,105 $114K
G0467 Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit 2,100 1,424 $108K
J3490 Unclassified drugs 11,070 6,202 $95K
80053 Comprehensive metabolic panel 12,220 10,505 $89K
96361 Intravenous infusion, hydration; each additional hour 3,662 3,419 $69K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 12,703 10,879 $59K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 2,457 2,300 $57K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 2,644 2,477 $54K
71046 Radiologic examination, chest; 2 views 2,739 2,670 $53K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1,838 1,641 $53K
96375 Therapeutic injection; each additional sequential IV push 3,283 3,006 $52K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 5,364 4,642 $50K
71275 Computed tomographic angiography, chest, with contrast material 468 452 $48K
84443 Thyroid stimulating hormone (TSH) 3,147 3,085 $48K
99223 Prolong inpt eval add15 m 553 536 $44K
83880 3,538 3,069 $44K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 3,146 2,968 $43K
74176 Computed tomography, abdomen and pelvis; without contrast material 674 650 $36K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 1,413 1,276 $32K
99282 Emergency department visit for the evaluation and management, low to moderate severity 811 800 $28K
83605 5,734 4,956 $28K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 683 676 $28K
80061 Lipid panel 1,678 1,667 $28K
84484 5,624 4,616 $28K
71045 Radiologic examination, chest; single view 4,677 4,274 $25K
97161 662 649 $24K
73630 848 743 $23K
72125 Computed tomography, cervical spine; without contrast material 283 277 $22K
90707 309 309 $21K
92552 1,101 1,098 $21K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1,865 1,779 $18K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 337 335 $18K
97139 1,350 334 $18K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 377 368 $17K
J7030 Infusion, normal saline solution , 1000 cc 4,524 3,822 $17K
83036 Hemoglobin; glycosylated (A1C) 1,178 1,172 $16K
99239 Hospital discharge day management, more than 30 minutes 307 298 $14K
82550 4,440 4,011 $14K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 536 519 $13K
83735 3,353 2,919 $12K
83690 3,576 3,282 $12K
85610 5,336 4,899 $11K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 1,272 930 $11K
84439 996 989 $11K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 440 426 $10K
71250 77 76 $9K
85730 3,105 2,930 $9K
87040 1,198 1,117 $8K
90674 379 377 $8K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 272 272 $8K
99070 10,485 9,289 $7K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 118 118 $7K
82010 1,756 1,629 $7K
97163 205 205 $7K
99233 Prolong inpt eval add15 m 207 103 $7K
J1885 Injection, ketorolac tromethamine, per 15 mg 1,977 1,772 $7K
72110 172 170 $7K
81001 2,825 2,670 $7K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 1,891 1,836 $6K
81003 3,644 3,474 $6K
90715 332 329 $6K
73030 414 387 $6K
99173 1,149 1,143 $5K
73562 309 279 $5K
81025 2,191 2,107 $5K
90658 201 199 $5K
82948 1,050 823 $4K
76705 Ultrasound, abdominal, real time with image documentation; limited 154 151 $4K
82553 898 800 $4K
85379 824 787 $4K
J2270 Injection, morphine sulfate, up to 10 mg 1,090 865 $4K
73130 199 184 $3K
Z7502 118 113 $3K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 139 133 $3K
73610 214 196 $3K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 780 770 $3K
80048 Basic metabolic panel (calcium, ionized) 496 483 $3K
90649 26 26 $2K
82150 811 779 $2K
80305 362 306 $2K
J0696 Injection, ceftriaxone sodium, per 250 mg 899 828 $2K
85378 671 646 $2K
87070 655 630 $2K
84145 433 379 $2K
0250 82 78 $2K
87088 527 501 $2K
99442 38 38 $2K
90700 84 84 $1K
87450 573 557 $1K
85651 894 877 $1K
86769 35 34 $1K
99281 Emergency department visit for the evaluation and management, self-limited or minor 46 45 $1K
96367 79 79 $1K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination 31 14 $1K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 915 724 $1K
0320 14 14 $1K
90716 81 81 $1K
99201 33 33 $922.23
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 12 12 $898.77
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 23 22 $885.22
84100 408 354 $873.91
J2405 Injection, ondansetron hydrochloride, per 1 mg 422 367 $873.01
90670 75 74 $823.50
87186 300 286 $780.57
80074 13 13 $776.43
90713 38 38 $764.51
82043 104 104 $733.24
87077 379 364 $684.94
J7050 Infusion, normal saline solution, 250 cc 233 206 $597.31
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 13 12 $548.08
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 37 26 $542.96
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 12 12 $485.05
72100 24 24 $474.15
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring 15 15 $450.00
72050 25 25 $434.10
90734 12 12 $418.16
96376 15 13 $394.30
H0033 Oral medication administration, direct observation 500 321 $391.62
0012A 13 13 $369.07
J1170 Injection, hydromorphone, up to 4 mg 79 69 $365.61
90633 28 28 $306.00
96127 49 49 $294.49
J2060 Injection, lorazepam, 2 mg 190 168 $281.52
73502 12 12 $280.51
94760 69 40 $280.42
3080F 263 257 $278.47
3077F 414 399 $278.47
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) 12 12 $240.67
J1100 Injection, dexamethasone sodium phosphate, 1 mg 93 78 $213.12
A4216 Sterile water, saline and/or dextrose, diluent/flush, 10 ml 86 77 $181.08
90744 13 13 $171.54
82140 40 37 $154.27
3079F 211 203 $119.79
90686 32 32 $117.45
J0131 Injection, acetaminophen, not otherwise specified,10 mg 109 107 $92.07
84481 12 12 $87.74
J7120 Ringers lactate infusion, up to 1000 cc 26 25 $87.08
36415 Collection of venous blood by venipuncture 69 65 $75.10
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 15 15 $69.95
84703 27 27 $46.94
86580 37 36 $46.07
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 42 40 $45.80
87086 Culture, bacterial; quantitative colony count, urine 15 14 $36.67
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 292 222 $30.40
J3010 Injection, fentanyl citrate, 0.1 mg 12 12 $30.22
3044F 13 12 $22.98
A4663 Blood pressure cuff only 24 24 $22.15
J2003 Injection, lidocaine hydrochloride, 1 mg 13 13 $5.40
80349 81 80 $1.85
A6402 Gauze, non-impregnated, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing 82 79 $1.02
91301 92 92 $0.75
G8510 Screening for depression is documented as negative, a follow-up plan is not required 30 30 $0.30
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) 12 12 $0.24
G8431 Screening for depression is documented as being positive and a follow-up plan is documented 19 19 $0.19
80329 34 25 $0.00
0250R 70 66 $0.00
3075F 63 61 $0.00
3074F 170 150 $0.00
J1741 Injection, ibuprofen, 100 mg 15 15 $0.00
3078F 169 155 $0.00
0270R 31 27 $0.00